Thursday, September 6th, 2018

How can I choose a high quality “Point of Care” drug test device/kit?


Just because a product has been “CE” marked is not a sign of quality. In fact, there have been cases where the CE mark has been falsely applied (i.e. not actually CE registered). In addition to CE marking, consider such things like FDA 510(k) clearance – as this indicates that the product has been through a rigorous quality audit (by the USA Food & Drug Administration). There are currently no UK quality accreditations for “Point of Care” drug test devices/kits? The ITS range of single and multi-panel CE marked, FDA 510(k) and CLIA waived drug test dips, cups and drug test kits, offer highly accurate, specific, sensitive and reliable point of care testing solutions. The ITS Premier Biotech Oral-Tox (rapid oral fluid drug test) has received FDA 510(k) clearance. One of only 2 devices that has achieved this quality assurance clearance, it demonstrates why it is one of the leading Oral Fluid drug testing point of care devices available on the market today.


Recent Posts

185 drivers failed roadside drug tests

185 drivers failed roadside drug tests

Police Scotland say 185 drivers failed roadside drug tests during their festive campaign. For the 1st time officers were able to test for drugs at the roadside. Drug tests for cannabis & cocaine resulted in 185 positive results from 480 drivers stopped. Almost 600 motorists breathalysed between 1 Dec-2 Jan were under the influence of drink/drugs. A total of 8687 drivers were stopped over the period, with 580 of those ....

Alcohol Awareness Week

Alcohol Awareness Week

Charity Alcohol Change UK have announced Alcohol Awareness Week (AAW) 2019 will take place from 11-17 November. Are you / your workplace doing anything to support and promote Alcohol Awareness Week?

New controls over prescription drugs Pregabalin and Gabapentin following rising fatalities

New controls over prescription drugs Pregabalin and Gabapentin following rising fatalities

Pregabalin and Gabapentin to be controlled as class C drugs from April 2019 Prescription drugs pregabalin and gabapentin are to be reclassified as class C controlled substances from April 2019, the government announced on 15 October 2018. The move comes after experts highlighted rising numbers of fatalities linked to the drugs. The change means it will be illegal to possess pregabalin and gabapentin without a prescription and it will be illegal to supply or sell them to others.